Get the Stockscreener App
4.23
4.51%
-0.20
After Hours:
4.15
-0.08
-1.89%
Trisalus Life Sciences Inc stock is traded at $4.23, with a volume of 30,392.
It is down -4.51% in the last 24 hours and down -22.39% over the past month.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
See More
Previous Close:
$4.43
Open:
$4.39
24h Volume:
30,392
Relative Volume:
0.41
Market Cap:
$160.06M
Revenue:
$15.33M
Net Income/Loss:
$-40.19M
P/E Ratio:
-2.4141
EPS:
-1.7522
Net Cash Flow:
-
1W Performance:
-9.42%
1M Performance:
-22.39%
6M Performance:
-17.22%
1Y Performance:
-25.79%
1-Day Range:
$4.23
$4.54
1-Week Range:
$4.18
$4.83
52-Week Range:
$3.50
$6.04
Trisalus Life Sciences Inc Stock (TLSI) Company Profile
Name
Trisalus Life Sciences Inc
Sector
Industry
Phone
415 336 8917
Address
6272 WEST 91ST AVENUE, WESTMINSTER
Compare TLSI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TLSI
Trisalus Life Sciences Inc
|
4.23 | 168.23M | 15.33M | -40.19M | 0 | -1.7522 |
|
ABT
Abbott Laboratories
|
126.19 | 223.66B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
104.92 | 157.95B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
392.73 | 153.02B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
90.24 | 117.42B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.31 | 47.61B | 5.69B | 4.15B | 623.10M | 6.95 |
Trisalus Life Sciences Inc Stock (TLSI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-25 | Initiated | Lake Street | Buy |
| Dec-17-24 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-11-24 | Initiated | ROTH MKM | Buy |
| Oct-25-24 | Initiated | Northland Capital | Outperform |
| Sep-16-24 | Initiated | Oppenheimer | Outperform |
| May-30-24 | Initiated | Canaccord Genuity | Buy |
View All
Trisalus Life Sciences Inc Stock (TLSI) Latest News
TriSalus Life Sciences Inc. Equity Warrant stock outlook for YEARChart Driven Opportunity Scanner with Alerts - Newser
Sector ETF performance correlation with TriSalus Life Sciences Inc.Volume Spike Detection for Early Breakouts - Newser
Should you wait for a breakout in TriSalus Life Sciences Inc.Fast Return Equity Forecast With Logic - Newser
Applying Wyckoff theory to TriSalus Life Sciences Inc. stockReal Time Alert System for Market Moves - Newser
What are analysts’ price targets for TriSalus Life Sciences Inc. in the next 12 monthsBreakout Stocks Opportunities Backed By Experts - jammulinksnews.com
What are TriSalus Life Sciences Inc. company’s key revenue driversExpert Picks Updates Backed By Experts - jammulinksnews.com
TriSalus Life Sciences launches preferred stock exchange - MSN
What catalysts could drive TriSalus Life Sciences Inc. Equity Warrant stock higher in 2025Expert Picks Entry Points For 2025 - jammulinksnews.com
When is the best time to exit TriSalus Life Sciences Inc. Equity WarrantMomentum Entry Alerts with Risk Control - Newser
Candlestick signals on TriSalus Life Sciences Inc. stock todayGrowth Watchlist for Long Term Positioning - Newser
Is this a good reentry point in TriSalus Life Sciences Inc.Capital Growth Summary Over Five Years - Newser
Why TriSalus Life Sciences Inc. Equity Warrant stock attracts strong analyst attentionAI-Powered Stock Trend Movement Analysis - Newser
TriSalus CEO to Showcase Solid Tumor Innovation at Canaccord Genuity Conference - Stock Titan
Visual analytics tools that track TriSalus Life Sciences Inc. Equity Warrant performanceFree Entry and Exit Strategy Optimizer Tool - Newser
TriSalus Life Sciences Inc. Equity Warrant Stock Performance After Earnings: Historical InsightsFree Short Term High Yield Stock Tips - Newser
News impact scoring models applied to TriSalus Life Sciences Inc. Equity WarrantFree Profit Target Stock Opportunity Monitor - Newser
How to read the order book for TriSalus Life Sciences Inc.Top Stock Picks with Forecast Accuracy - Newser
TriSalus Life Sciences to Participate in the Canaccord Genuity 45th Annual Growth Conference - Lelezard
What makes TriSalus Life Sciences Inc. Equity Warrant stock price move sharplyConsistent Income Focused Trade List Analyzed - metal.it
Forecasting TriSalus Life Sciences Inc. Equity Warrant price range with options dataFree Growth Based Stock Signal Screener - Newser
TriSalus Life Sciences Announces Q2 Earnings Call: Cancer Treatment Innovation Updates Expected - Stock Titan
TriSalus Life Sciences Inc. Breaks Losing Streak — Is the Trend ReversingBuy Signal Based on Chart Analysis Confirmed - metal.it
Is It Too Late to Sell TriSalus Life Sciences Inc.Price Action Based Buy Opportunity List Published - metal.it
Does TriSalus Life Sciences Inc. Equity Warrant stock pay reliable dividendsTechnical Trend Forecast for Investors - Newser
Chart based exit strategy for TriSalus Life Sciences Inc. Equity WarrantFree Technical Stock Breakout Predictions - Newser
How TriSalus Life Sciences Inc. stock performs during market volatilityFree ROI Driven Equity Selection With Safety - Newser
Key External Factors That Drive TriSalus Life Sciences Inc. Stock Price MovementsFree Real Profit Trade Plan Suggestions - Newser
Can trapped investors hope for a rebound in TriSalus Life Sciences Inc.Real Time Screener for Growth Trades - Newser
Is TriSalus Life Sciences Inc. Equity Warrant Stock a Good Fit for Conservative InvestorsCapital Growth Plan for New Investors - Newser
How TriSalus Life Sciences Inc. Equity Warrant stock performs during market volatilityEntry Confirmation Using Short-Term Forecasting - Newser
Combining machine learning predictions for TriSalus Life Sciences Inc.Real Time Alert System for Market Moves - Newser
What are the technical indicators suggesting about TriSalus Life Sciences Inc. Equity WarrantPost Market Planner That Work - jammulinksnews.com
Published on: 2025-07-28 14:52:06 - metal.it
What are TriSalus Life Sciences Inc. Equity Warrant company’s key revenue driversInvest confidently with professional market insights - jammulinksnews.com
Does TriSalus Life Sciences Inc. Equity Warrant stock perform well during market downturnsExceptional gains - jammulinksnews.com
What is the risk reward ratio of investing in TriSalus Life Sciences Inc. stockSuperior portfolio returns - jammulinksnews.com
Trisalus Life Sciences Inc Stock (TLSI) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):